xista science ventures logo

xista science ventures

Europe, Niederosterreich, Austria, Klosterneuburg

Description

Xista Science Ventures, based in Klosterneuburg, Austria, is a prominent early-stage venture capital firm specializing in deep tech and science-based startups. Spun out of the renowned Institute of Science and Technology Austria (IST Austria), the firm maintains strong ties to cutting-edge academic research, positioning itself as a key player in translating scientific breakthroughs into commercial successes. Their investment thesis centers on disruptive innovations across various sectors, including life sciences, biotech, quantum computing, artificial intelligence, and advanced materials, targeting companies that leverage profound scientific insights to solve complex problems.

The firm primarily focuses on pre-seed and seed-stage investments, often acting as the first institutional investor for promising ventures. Xista Science Ventures announced a dedicated fund of €35 million in 2021, underscoring its commitment to fostering high-potential scientific enterprises. Typical initial cheque sizes for their investments range from €500,000 to €2 million, with the capacity for follow-on funding as companies achieve significant milestones. While their primary geographic focus is Europe, particularly the DACH region and Central Europe, they remain open to exceptional opportunities globally that align with their deep tech mandate.

Beyond capital infusion, Xista Science Ventures provides comprehensive support to its portfolio companies, leveraging its deep scientific expertise and extensive network. This includes strategic guidance on intellectual property, assistance with team building, business development, and access to a robust ecosystem of scientific and industry experts. Their hands-on approach aims to accelerate the growth of science-driven startups, helping them navigate the complexities of commercialization and scale their groundbreaking technologies from laboratory to market.

Investor Profile

xista science ventures has backed more than 26 startups, with 0 new investments in the last 12 months alone. The firm has led 18 rounds, about 69% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Pre Seed, Series A rounds (top funding stages).
  • Majority of deals are located in Austria, Sweden, France.
  • Strong thematic focus on Biotechnology, Medical, Artificial Intelligence (AI).
  • Typical check size: $500K – $2M.

Stage Focus

  • Seed (46%)
  • Pre Seed (35%)
  • Series A (19%)

Country Focus

  • Austria (81%)
  • Sweden (8%)
  • France (4%)
  • Philippines (4%)
  • Slovenia (4%)

Industry Focus

  • Biotechnology
  • Medical
  • Artificial Intelligence (Ai)
  • Life Science
  • Health Care
  • Information Technology
  • Predictive Analytics
  • Risk Management
  • Supply Chain Management
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does xista science ventures frequently co-invest with?

Nina Capital
Europe, Catalonia, Spain, Barcelona
Co-Investments: 3
Speedinvest
Europe, Wien, Austria, Vienna
Co-Investments: 3
aws Gründungsfonds
Europe, Wien, Austria, Vienna
Co-Investments: 2
Ventech
Europe, Ile-de-France, France, Paris
Co-Investments: 3
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 2
seed + speed Ventures
Europe, Berlin, Germany, Berlin
Co-Investments: 3
Segnalita
Europe, Tirol, Austria, Wattens
Co-Investments: 3
KOMPAS VC
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 2
tecnet equity
Europe, Niederosterreich, Austria, Sankt Polten
Co-Investments: 5
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 3

Which angels does xista science ventures often collaborate with?

TT
Europe, Slovenia
Shared Deals: 1

What are some of recent deals done by xista science ventures?

Syntropic

Austria, Pangasinan, Philippines

Syntropic is a medical device company.

MedicalMedical Device
SeedApr 4, 2024
G.ST Antivirals

Vienna, Wien, Austria

G.ST Antivirals is a clinical-stage biotech company that develops broad-spectrum antivirals against infections of the respiratory tract.

BiotechnologyLife Science
Series AJan 25, 2024
Amount Raised: $6,724,293
HEPHAISTOS-Pharma

Orsay, Ile-de-France, France

Hephaistos Pharma is a biotech company developing oncology treatments.

BiotechnologyOncology
SeedJan 23, 2024
Amount Raised: $4,885,898
Rivus Batteries

Göteborg, Vastra Gotaland, Sweden

Organic electrolytes for flow batteries making grid-scale energy storage cost-effective and eco-friendly

BatteryEnergy Storage
SeedDec 5, 2023
Amount Raised: $566,710
VALANX Biotech

Graz, Steiermark, Austria

VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.

BiotechnologyHealth CareMedicalPharmaceutical
SeedNov 7, 2023
Amount Raised: $2,460,230
infrared.city

Vienna, Wien, Austria

SaaS for climate simulations

Environmental EngineeringSimulationSoftware
Pre SeedOct 10, 2023
Amount Raised: $1,060,333
subdron

Lauterach, Vorarlberg, Austria

subdron focuses on data processing in underwater inspections and autonomous underwater navigation.

ElectronicsNavigation
Pre SeedJul 18, 2023
Amount Raised: $1,459,695
ReCatalyst

Ljubljana, Ljubljana Urban Commune, Slovenia

ReCatalyst develops next-generation PEM fuel cell catalysts.

ChemicalNanotechnology
SeedJul 12, 2023
Amount Raised: $1,893,895
Prewave

Vienna, Wien, Austria

Prewave is an AI risk and sustainability monitoring platform for purchasing, supply chain, and sustainability managers.

Artificial Intelligence (AI)Information TechnologyPredictive AnalyticsRisk ManagementSupply Chain Management
Series AMay 9, 2023
Amount Raised: $19,736,409
Sarcura

Klosterneuburg, Niederosterreich, Austria

Cell Therapy transformed cancer treatment. Sarcura will transform cell therapy manufacturing.

BiotechnologyLife ScienceOncologySemiconductor
SeedNov 17, 2022
Amount Raised: $7,304,617